She says, “It's going to take an effort of will on the part of all of us to be willing to share vaccines and to be willing to make sure that we make vaccines accessible to everybody.” Allison McGeer is an infectious disease expert at Mount Sinai Hospital in Toronto, and understands the importance of stopping the spread. With two-thirds of the world engaged, this promise has the potential to level the playing field when it comes to stopping COVID-19.ĭr. The program has been described as a lifeline for lower income funded nations and countries that have no bilateral deals with manufacturers. So far, there are over 90 countries that will be supported, including most African countries. The COVAX goal is to have 2 billion doses of vaccines available by the end of 2021 for countries that otherwise can’t secure them on their own. This is where COVAX comes in, an initiative launched in April 2020 by the World Health Organization (WHO), the European Commission and France in response to the pandemic. The rest of the world is at the back of the line. Yet so far, only about 30 nations have received the precious vials of hope. While limited scientific data is still raising questions, including how long the vaccines will protect us, vaccines that have won approval in record time, are so far, proving to be safe and effective. As vaccines rollout across Canada, and we watch other nations getting their shots, there is a collective exhale.Īt backyard bonfires and in grocery store lines people are buzzing with new hope that the COVID-19 vaccines will be the weapons to win this war.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |